Bartlett & Co Wealth Management’s Zivo Bioscience, Inc. Common Stock ZIVO Stock Holding History

Bartlett & Co Wealth Management’s Portfolio ZIVO Stock Details ZIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-166	Closed	-$216	–	1229
2023 Q4	$216	Sell	166 -1	-0.6%	-$3	﹤0.01%	1213
2023 Q3	$1.3K	Hold	167	–	–	﹤0.01%	1100
2023 Q2	$2.42K	Hold	167	–	–	﹤0.01%	1050
2023 Q1	$3.08K	Hold	167	–	–	﹤0.01%	951
2022 Q4	$2.5K	Hold	167	–	–	﹤0.01%	997
2022 Q3	$2.8K	Hold	167	–	–	﹤0.01%	1012
2022 Q2	$3.92K	Hold	167	–	–	﹤0.01%	1071
2022 Q1	$3.88K	Buy	+167	New	+$3.33K	﹤0.01%	939
2021 Q4	–	Sell	-167	Closed	-$4.56K	–	926
2021 Q3	$4.56K	Hold	167	–	–	﹤0.01%	776
2021 Q2	$4.74K	Buy	+167	New	+$4.54K	﹤0.01%	766

Bartlett & Co Wealth Management's ZIVO Position: Q1 2024 in Review

Bartlett & Co Wealth Management sold out of Zivo Bioscience, Inc. Common Stock (ZIVO) in Q1 2024, closing a stake of 166 shares — an estimated $216 sold.

Bartlett & Co Wealth Management first reported a position in ZIVO in Q2 2021 and held it in 10 quarters. The position peaked at $4.74K in Q2 2021. 0 funds tracked by Wall St. Rank hold ZIVO as of Q1 2024.

Bartlett & Co Wealth Management reported no remaining Zivo Bioscience, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Bartlett & Co Wealth Management sold 166 Zivo Bioscience, Inc. Common Stock shares in Q1 2024, an estimated $216.
Bartlett & Co Wealth Management first reported a position in Zivo Bioscience, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
Bartlett & Co Wealth Management's Zivo Bioscience, Inc. Common Stock position peaked at $4.74K in Q2 2021.
0 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Common Stock as of Q1 2024.

Based on Bartlett & Co Wealth Management's 13F filing for Q1 2024, filed 9 May 2024.